Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Bulletin Du Cancer
|
December 18, 2021
CAR-T cells for pediatric brain tumors: Present and future
Amaury Leruste, Kevin Beccaria, François Doz
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 17, 2022
Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again
Adrienne H Long, Daniel A Morgenstern, Amaury Leruste, et al.
Tumori
|
April 20, 2021
Controversies on the possible role of immune checkpoint inhibitors in pediatric cancers: balancing irAEs and efficacy
Olga Nigro, Andrea Ferrari, Michela Casanova, et al.
Bulletin Du Cancer
|
July 26, 2025
[Treatment guidelines for patients with relapsed/progressive high-risk neuroblastoma from the Neuroblastoma Committee of the French Society of Pediatric Oncology]
Pablo Berlanga, Claudia Pasqualini, Marion Gambart, et al.
Journal of Pediatric Hematology/Oncology
|
January 29, 2022
Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 Patients
Victor Pereira, Sabah Boudjemaa, Caroline Besson, et al.
Haematologica
|
March 3, 2022
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study
Marie Emilie Dourthe, Aurélie Phulpin, Anne Auperin, et al.
British Journal of Haematology
|
February 18, 2026
Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real-world study
Marlène Pouthier, Nathalie Garnier, Amaury Leruste, et al.
Pediatric Blood & Cancer
|
October 22, 2024
Outcome of childhood ALK-positive anaplastic large cell lymphoma relapses: Real-life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children
Victor Pereira, Maël Barthoulot, Nathalie Aladjidi, et al.
Oncotarget
|
April 22, 2017
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
Wilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, et al.
Cell Reports
|
November 16, 2017
High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors
Céline Chauvin, Amaury Leruste, Arnault Tauziede-Espariat, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Bulletin Du Cancer
|
December 18, 2021
CAR-T cells for pediatric brain tumors: Present and future
Amaury Leruste, Kevin Beccaria, François Doz
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 17, 2022
Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again
Adrienne H Long, Daniel A Morgenstern, Amaury Leruste, et al.
Tumori
|
April 20, 2021
Controversies on the possible role of immune checkpoint inhibitors in pediatric cancers: balancing irAEs and efficacy
Olga Nigro, Andrea Ferrari, Michela Casanova, et al.
Bulletin Du Cancer
|
July 26, 2025
[Treatment guidelines for patients with relapsed/progressive high-risk neuroblastoma from the Neuroblastoma Committee of the French Society of Pediatric Oncology]
Pablo Berlanga, Claudia Pasqualini, Marion Gambart, et al.
Journal of Pediatric Hematology/Oncology
|
January 29, 2022
Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 Patients
Victor Pereira, Sabah Boudjemaa, Caroline Besson, et al.
Haematologica
|
March 3, 2022
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study
Marie Emilie Dourthe, Aurélie Phulpin, Anne Auperin, et al.
British Journal of Haematology
|
February 18, 2026
Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real-world study
Marlène Pouthier, Nathalie Garnier, Amaury Leruste, et al.
Pediatric Blood & Cancer
|
October 22, 2024
Outcome of childhood ALK-positive anaplastic large cell lymphoma relapses: Real-life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children
Victor Pereira, Maël Barthoulot, Nathalie Aladjidi, et al.
Oncotarget
|
April 22, 2017
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
Wilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, et al.
Cell Reports
|
November 16, 2017
High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors
Céline Chauvin, Amaury Leruste, Arnault Tauziede-Espariat, et al.
Page
of 3